These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27190045)

  • 1. Lifetime Number of Ovulatory Cycles and Risks of Ovarian and Endometrial Cancer Among Postmenopausal Women.
    Yang HP; Murphy KR; Pfeiffer RM; George N; Garcia-Closas M; Lissowska J; Brinton LA; Wentzensen N
    Am J Epidemiol; 2016 May; 183(9):800-14. PubMed ID: 27190045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States).
    Moorman PG; Schildkraut JM; Calingaert B; Halabi S; Vine MF; Berchuck A
    Cancer Causes Control; 2002 Nov; 13(9):807-11. PubMed ID: 12462545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Risk of Ovarian Cancer Increases with an Increase in the Lifetime Number of Ovulatory Cycles: An Analysis from the Ovarian Cancer Cohort Consortium (OC3).
    Trabert B; Tworoger SS; O'Brien KM; Townsend MK; Fortner RT; Iversen ES; Hartge P; White E; Amiano P; Arslan AA; Bernstein L; Brinton LA; Buring JE; Dossus L; Fraser GE; Gaudet MM; Giles GG; Gram IT; Harris HR; Bolton JH; Idahl A; Jones ME; Kaaks R; Kirsh VA; Knutsen SF; Kvaskoff M; Lacey JV; Lee IM; Milne RL; Onland-Moret NC; Overvad K; Patel AV; Peters U; Poynter JN; Riboli E; Robien K; Rohan TE; Sandler DP; Schairer C; Schouten LJ; Setiawan VW; Swerdlow AJ; Travis RC; Trichopoulou A; van den Brandt PA; Visvanathan K; Wilkens LR; Wolk A; Zeleniuch-Jacquotte A; Wentzensen N;
    Cancer Res; 2020 Mar; 80(5):1210-1218. PubMed ID: 31932455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifetime ovulatory cycles and ovarian cancer risk in 2 Italian case-control studies.
    Pelucchi C; Galeone C; Talamini R; Bosetti C; Montella M; Negri E; Franceschi S; La Vecchia C
    Am J Obstet Gynecol; 2007 Jan; 196(1):83.e1-7. PubMed ID: 17240246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico.
    Salazar-Martinez E; Lazcano-Ponce EC; Gonzalez Lira-Lira G; Escudero-De los Rios P; Salmeron-Castro J; Hernandez-Avila M
    Cancer Res; 1999 Aug; 59(15):3658-62. PubMed ID: 10446978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer.
    Schildkraut JM; Bastos E; Berchuck A
    J Natl Cancer Inst; 1997 Jul; 89(13):932-8. PubMed ID: 9214672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifetime number of ovulatory cycles and epithelial ovarian cancer risk in African American women.
    Peres LC; Moorman PG; Alberg AJ; Bandera EV; Barnholtz-Sloan J; Bondy M; Cote ML; Funkhouser E; Peters ES; Schwartz AG; Terry PD; Abbott SE; Camacho F; Wang F; Schildkraut JM
    Cancer Causes Control; 2017 May; 28(5):405-414. PubMed ID: 28251458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of reproductive factors on mortality after epithelial ovarian cancer diagnosis.
    Robbins CL; Whiteman MK; Hillis SD; Curtis KM; McDonald JA; Wingo PA; Kulkarni A; Marchbanks PA
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2035-41. PubMed ID: 19589914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovulation and risk of epithelial ovarian cancer.
    Purdie DM; Bain CJ; Siskind V; Webb PM; Green AC
    Int J Cancer; 2003 Mar; 104(2):228-32. PubMed ID: 12569579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup.
    Schildkraut JM; Moorman PG; Bland AE; Halabi S; Calingaert B; Whitaker R; Lee PS; Elkins-Williams T; Bentley RC; Marks JR; Berchuck A
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):585-93. PubMed ID: 18349276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incessant ovulation, mucin 1 immunity, and risk for ovarian cancer.
    Terry KL; Titus-Ernstoff L; McKolanis JR; Welch WR; Finn OJ; Cramer DW
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):30-5. PubMed ID: 17220329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for epithelial ovarian tumours of borderline malignancy.
    Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
    Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology of endometrial and ovarian cancer.
    Cramer DW
    Hematol Oncol Clin North Am; 2012 Feb; 26(1):1-12. PubMed ID: 22244658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of ovarian hormone exposure and gynecological cancer risk in Korean women: the Korean Heart Study.
    Jung KJ; Park C; Yun YD; Jee SH
    Cancer Epidemiol; 2016 Apr; 41():1-7. PubMed ID: 26773407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study.
    Tung KH; Goodman MT; Wu AH; McDuffie K; Wilkens LR; Kolonel LN; Nomura AM; Terada KY; Carney ME; Sobin LH
    Am J Epidemiol; 2003 Oct; 158(7):629-38. PubMed ID: 14507598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifetime ovulations and epithelial ovarian cancer risk and survival: A systematic review and meta-analysis.
    Fu Z; Taylor S; Modugno F
    Gynecol Oncol; 2022 Jun; 165(3):650-663. PubMed ID: 35473671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of anovulation factors on pre- and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis.
    Tung KH; Wilkens LR; Wu AH; McDuffie K; Nomura AM; Kolonel LN; Terada KY; Goodman MT
    Am J Epidemiol; 2005 Feb; 161(4):321-9. PubMed ID: 15692075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary cadmium intake and risk of breast, endometrial and ovarian cancer in Danish postmenopausal women: a prospective cohort study.
    Eriksen KT; Halkjær J; Sørensen M; Meliker JR; McElroy JA; Tjønneland A; Raaschou-Nielsen O
    PLoS One; 2014; 9(6):e100815. PubMed ID: 24963789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.
    Kotsopoulos J; Lubinski J; Gronwald J; Cybulski C; Demsky R; Neuhausen SL; Kim-Sing C; Tung N; Friedman S; Senter L; Weitzel J; Karlan B; Moller P; Sun P; Narod SA;
    Int J Cancer; 2015 Sep; 137(5):1136-46. PubMed ID: 25482078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Endogenous Pregnenolone, Progesterone, and Related Metabolites with Risk of Endometrial and Ovarian Cancers in Postmenopausal Women: The B
    Trabert B; Geczik AM; Bauer DC; Buist DSM; Cauley JA; Falk RT; Gierach GL; Hue TF; Lacey JV; LaCroix AZ; Michels KA; Tice JA; Xu X; Brinton LA; Dallal CM
    Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2030-2037. PubMed ID: 34465588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.